Literature DB >> 10946280

Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.

D Anhuf1, M Weissenbach, J Schmitz, R Sobota, H M Hermanns, S Radtke, S Linnemann, I Behrmann, P C Heinrich, F Schaper.   

Abstract

Stimulation of the IL-6R complex leads to Src homology domain containing tyrosine phosphatase 2 (SHP2) recruitment to the receptor subunit gp130 and its subsequent tyrosine phosphorylation. SHP2 is a two-SH2 domain-containing protein tyrosine phosphatase that is activated by many cytokines and growth factors. SHP2 counteracts the activation of transcription factors of the STAT family and the induction of IL-6-responsive genes. Tyrosine 759 of gp130, the signal transducing subunit of the IL-6R complex, is essential for the phosphorylation of SHP2. Mutation of tyrosine 759 to phenylalanine leads to an enhanced inducibility of IL-6-dependent genes. Here we demonstrate that no further tyrosines in the cytoplasmic part of gp130 are required for the phosphorylation of SHP2. We also tested whether the tyrosine 759 motifs in both subunits of the gp130 dimer are required for SHP2 association and tyrosine phosphorylation. Interestingly, one SHP2-recruiting phosphotyrosine motif in a single chain of the gp130 dimer is sufficient to mediate SHP2 association to the gp130 receptor subunit and its tyrosine phosphorylation as well as to attenuate IL-6-dependent gene induction. Furthermore, we show that repression of gene induction via Y759 does not require the presence of the SHP2 and STAT recruitment sites within the same receptor subunit, but within the same receptor complex. The Y759 motif in gp130 also attenuates gene induction mediated by the oncostatin M and leukemia inhibitory factor receptor complexes, which both contain gp130 as the shared subunit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946280     DOI: 10.4049/jimmunol.165.5.2535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 2.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

3.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

Review 4.  Promoting myelin repair and return of function in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Linnea Asp; Dipankar J Dutta; Kristina Navrazhina; Trinh Pham; John N Mariani; Azeb Tadesse Argaw; Carmen V Melendez-Vasquez; Gareth R John
Journal:  FEBS Lett       Date:  2011-08-18       Impact factor: 4.124

5.  Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling.

Authors:  Yi Yu; Shuchen Gu; Wenjian Li; Chuang Sun; Fenfang Chen; Mu Xiao; Lei Wang; Dewei Xu; Ye Li; Chen Ding; Zongping Xia; Yi Li; Sheng Ye; Pinglong Xu; Bin Zhao; Jun Qin; Ye-Guang Chen; Xia Lin; Xin-Hua Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

Review 6.  Targeting oligodendrocyte protection and remyelination in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Sean Mahase; Dipankar J Dutta; Virginie Bonnamain; Azeb T Argaw; Gareth R John
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

7.  The transcription co-repressor TLE1 interacted with the intracellular region of gpl30 through its Q domain.

Authors:  Fei Liu; Yin Liu; Demin Li; Yong Zhu; Weiming Ouyang; Xin Xie; Boquan Jin
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

Review 8.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.

Authors:  Patrick Fischer; Ute Lehmann; Radoslaw M Sobota; Jochen Schmitz; Claudia Niemand; Sonja Linnemann; Serge Haan; Iris Behrmann; Akihiko Yoshimura; James A Johnston; Gerhard Müller-Newen; Peter C Heinrich; Fred Schaper
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.

Authors:  Houqi Liu; Shanrong Liu; Shuping Tang; Kaihong Ji; Fengmei Wang; Shijie Hu
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.